Combined sedation with midazolam/propofol for gastrointestinal endoscopy in elderly patients
<p>Abstract</p> <p>Background</p> <p>Although gastrointestinal endoscopy with sedation is increasingly performed in elderly patients, data on combined sedation with midazolam/propofol are very limited for this age group.</p> <p>Methods</p> <p>We...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-01-01
|
Series: | BMC Gastroenterology |
Online Access: | http://www.biomedcentral.com/1471-230X/10/11 |
id |
doaj-16100ce732cc4f1f891b8dd01676d27c |
---|---|
record_format |
Article |
spelling |
doaj-16100ce732cc4f1f891b8dd01676d27c2020-11-25T03:57:03ZengBMCBMC Gastroenterology1471-230X2010-01-011011110.1186/1471-230X-10-11Combined sedation with midazolam/propofol for gastrointestinal endoscopy in elderly patientsSchlief Hans-EugenHardt ChristianKerker AstridDumoulin Franz<p>Abstract</p> <p>Background</p> <p>Although gastrointestinal endoscopy with sedation is increasingly performed in elderly patients, data on combined sedation with midazolam/propofol are very limited for this age group.</p> <p>Methods</p> <p>We retrospectively analyzed 454 endoscopic procedures in 347 hospitalized patients ≥ 70 years who had received combined sedation with midazolam/propofol. 513 endoscopic procedures in 397 hospitalized patients < 70 years during the observation period served as controls. Characteristics of endoscopic procedures, co-morbidity, complications and mortality were compared.</p> <p>Results</p> <p>Elderly patients had a higher level of co-morbidity and needed lower mean propofol doses for sedation. We observed no major complication and no difference in the number of minor complications. The procedure-associated mortality was 0%; the 28-day mortality was significantly higher in the elderly (2.9% vs. 1.0%).</p> <p>Conclusions</p> <p>In this study on elderly patients with high level co-morbidity, a favourable safety profile was observed for a combined sedation with midazolam/propofol with a higher sensitivity to propofol in the elderly.</p> http://www.biomedcentral.com/1471-230X/10/11 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Schlief Hans-Eugen Hardt Christian Kerker Astrid Dumoulin Franz |
spellingShingle |
Schlief Hans-Eugen Hardt Christian Kerker Astrid Dumoulin Franz Combined sedation with midazolam/propofol for gastrointestinal endoscopy in elderly patients BMC Gastroenterology |
author_facet |
Schlief Hans-Eugen Hardt Christian Kerker Astrid Dumoulin Franz |
author_sort |
Schlief Hans-Eugen |
title |
Combined sedation with midazolam/propofol for gastrointestinal endoscopy in elderly patients |
title_short |
Combined sedation with midazolam/propofol for gastrointestinal endoscopy in elderly patients |
title_full |
Combined sedation with midazolam/propofol for gastrointestinal endoscopy in elderly patients |
title_fullStr |
Combined sedation with midazolam/propofol for gastrointestinal endoscopy in elderly patients |
title_full_unstemmed |
Combined sedation with midazolam/propofol for gastrointestinal endoscopy in elderly patients |
title_sort |
combined sedation with midazolam/propofol for gastrointestinal endoscopy in elderly patients |
publisher |
BMC |
series |
BMC Gastroenterology |
issn |
1471-230X |
publishDate |
2010-01-01 |
description |
<p>Abstract</p> <p>Background</p> <p>Although gastrointestinal endoscopy with sedation is increasingly performed in elderly patients, data on combined sedation with midazolam/propofol are very limited for this age group.</p> <p>Methods</p> <p>We retrospectively analyzed 454 endoscopic procedures in 347 hospitalized patients ≥ 70 years who had received combined sedation with midazolam/propofol. 513 endoscopic procedures in 397 hospitalized patients < 70 years during the observation period served as controls. Characteristics of endoscopic procedures, co-morbidity, complications and mortality were compared.</p> <p>Results</p> <p>Elderly patients had a higher level of co-morbidity and needed lower mean propofol doses for sedation. We observed no major complication and no difference in the number of minor complications. The procedure-associated mortality was 0%; the 28-day mortality was significantly higher in the elderly (2.9% vs. 1.0%).</p> <p>Conclusions</p> <p>In this study on elderly patients with high level co-morbidity, a favourable safety profile was observed for a combined sedation with midazolam/propofol with a higher sensitivity to propofol in the elderly.</p> |
url |
http://www.biomedcentral.com/1471-230X/10/11 |
work_keys_str_mv |
AT schliefhanseugen combinedsedationwithmidazolampropofolforgastrointestinalendoscopyinelderlypatients AT hardtchristian combinedsedationwithmidazolampropofolforgastrointestinalendoscopyinelderlypatients AT kerkerastrid combinedsedationwithmidazolampropofolforgastrointestinalendoscopyinelderlypatients AT dumoulinfranz combinedsedationwithmidazolampropofolforgastrointestinalendoscopyinelderlypatients |
_version_ |
1724462249872982016 |